Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis
批准号:
9245140
负责人:
JUN YAN
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-20 至 2022-03-31
关键词:
AddressBiologyCCL20 geneCell ProliferationCellsChronicChronic small plaque psoriasisClinicalDataDermalDermisDevelopmentDiseaseHealthHomeostasisHumanImmuneImmunologic SurveillanceIn VitroIndividualInfectionInfiltrationInflammationInflammatoryInterleukin-1Interleukin-1 betaInterleukin-12Interleukin-17InterleukinsLaboratoriesLeukocytesMemoryModelingMusPathogenesisPathogenicityPatientsPhase II Clinical TrialsPhenotypePlayPopulationProductionPsoriasisRecurrent diseaseRegulationRoleSCID MiceSignal PathwaySignal TransductionSkinSourceStreptococcal InfectionsSymbiosisT-LymphocyteT-Lymphocyte SubsetsTestingTreatment EfficacyXenograft Modelbasechemokinechronic inflammatory skincytokineindividual patientinsightinterleukin-23keratinocytemicrobialmicroorganismneglectnovelpathogenperipheral bloodreceptorskin disorderskin lesionskin microbiotatraffickingγδ T cells
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Psoriasis is one of the most common immune-related chronic inflammatory skin disorders. Clinical
observations suggest that streptococcal infection has an intimate relationship in triggering psoriasis onset and
exacerbating chronic psoriasis. Humanized IL-12/IL-23 p40, IL-17A, and IL-17 receptor mAbs have shown
remarkable therapeutic efficacy for the treatment of chronic plaque psoriasis, suggesting IL-23/IL-17 axis plays
important roles in psoriasis pathogenesis. Our previous studies have demonstrated that dermal γδ T cells are
the major IL-17 producers in the skin and are critical in psoriasis pathogenesis. Dermal γδ T cells are
phenotypically and functionally unique. However, it is largely unknown how these cells are critically regulated in
mice and humans, particularly in the context of microbial infection and skin microbial commensal alteration.
In the proposal, we provided preliminary data suggesting that dermal γδ T cells play critical roles in skin
immune surveillance and inflammation. IL-1β signaling pathway plays a crucial role in regulating dermal γδ T
cell proliferation, IL-17 production, and probably trafficking in mice. Pathogen products stimulated skin cells to
produce IL-1β. In addition, we showed that skin microbiota from psoriatic skin has been substantially altered
compared to that in healthy control skin. Human Vγ9Vδ2 T cells were capable of secreting IL-17 and
significantly decreased in the peripheral blood of psoriatic patients but increased in psoriatic skin lesions and
produced large amounts of IL-17. Based on these preliminary findings, we hypothesize that dysregulated
dermal γδ T cells via IL-1 signaling by pathogen infection or skin microbiota alteration play an essential
role in psoriasis pathogenesis. Three Aims are proposed to address this hypothesis. Aim 1 determines the
role of IL-1 signaling in psoriasis immunopathogenesis. We will test the hypothesis that IL-1 signaling regulates
psoriasis immunopathogenesis through 1) directly activating dermal γδ T cells; 2) stimulating KC to secrete
chemokines which chemoattract more IL-17-producing γδ T cells from periphery into dermis thus amplifying
skin inflammatory cascade; 3) generating memory-like dermal γδ T cells for disease relapse. Aim 2 examines
how skin commensal microorganisms regulate dermal γδ T cell homeostasis in healthy skins and dermal γδ T
cell activation in skin inflammation. Aim 3 determines how human Vγ9 T cells are regulated by pathogen
components or skin microbiota alteration for expansion and IL-17 production. Human skin/SCID mouse
xenograft model will be established to determine the pathogenic roles of human Vγ9 T cells and microbial
infection/commensal alteration in psoriasis pathogenesis. It is believed that this study will provide new insights
into understanding the biology of dermal γδ T cell population and immuno-pathogenesis of psoriasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10333206
-
项目类别:
-
资助金额:$73.55万
-
财政年份:2020
-
负责人:JUN YAN
-
依托单位:
Administrative Core
-
批准号:10577764
-
项目类别:
-
资助金额:$68.6万
-
财政年份:2020
-
负责人:JUN YAN
-
依托单位:
Administrative Core
-
批准号:10093104
-
项目类别:
-
资助金额:$73.77万
-
财政年份:2020
-
负责人:JUN YAN
-
依托单位:
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer
-
批准号:9261875
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2017
-
负责人:JUN YAN
-
依托单位:
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis
-
批准号:9892950
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2017
-
负责人:JUN YAN
-
依托单位:
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer
-
批准号:10115632
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2017
-
负责人:JUN YAN
-
依托单位:
Regulation of GC B Cells by Transcription Factor STAT3
-
批准号:9091809
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2016
-
负责人:JUN YAN
-
依托单位:
Regulation of GC B Cells by Transcription Factor STAT3
-
批准号:9234461
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2016
-
负责人:JUN YAN
-
依托单位:
Role of STAT3 Signaling in GC B Cell Regulation
-
批准号:8967897
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2015
-
负责人:JUN YAN
-
依托单位:
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
-
批准号:8110645
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2009
-
负责人:JUN YAN
-
依托单位:
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
-
批准号:8301023
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2009
-
负责人:JUN YAN
-
依托单位:
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
-
批准号:7708382
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2009
-
负责人:JUN YAN
-
依托单位:
TARGETING OF PHAGOCYTE & NK CELL CR3 TO TUMOR-BOUND IC3B
-
批准号:7262332
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2000
-
负责人:JUN YAN
-
依托单位:
TARGETING OF PHAGOCYTE & NK CELL CR3 TO TUMOR-BOUND IC3B
-
批准号:6698126
-
项目类别:
-
资助金额:$25.92万
-
财政年份:2000
-
负责人:JUN YAN
-
依托单位:
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity
-
批准号:7675433
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2000
-
负责人:JUN YAN
-
依托单位:
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity
-
批准号:7290977
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2000
-
负责人:JUN YAN
-
依托单位:
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity
-
批准号:7473266
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2000
-
负责人:JUN YAN
-
依托单位:
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity
-
批准号:7207827
-
项目类别:
-
资助金额:$23.06万
-
财政年份:2000
-
负责人:JUN YAN
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: